Not a member? Sign up for free!

PsychU Announces 2018 Annual Theme #UICanPreventSuicide

It is estimated that 44,153 Americans will die by suicide this year. Individuals with mental illness are especially vulnerable, having some of the highest suicide risk factors. PsychU is highlighting suicide prevention in its annual theme: U & I Can Prevent Suicide… Together #UICanPreventSuicide. If you or someone you know is in crisis, call: Suicide Prevention Hotline/Lifeline 1-800-273-TALK (8255) Or text: Crisis Text Line 741-741

Improving mental health care… together

In just two years, the PsychU community has grown to over 37,000 physicians, clinicians, care managers, nurses, pharmacists, payers, administrators, and mental health professionals. Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.

Join Us

Participate In Forward-Thinking Forums - Live & Online

PsychU forums provide a platform for knowledge-sharing, collaborative thinking, and forward-thinking discussion on the treatment best practices, innovative programs, and industry developments shifting the trajectory of mental health care across the world. Participate in the comfort of your home, office, or at a local meeting in your region! All events are free for members.

Join Now To Attend

On-Demand Library Of Clinical Research, Treatment Best Practices & Educational Resources

PsychU’s online resource center has evolved into the premier information source for the mental health field. Become a member today and gain instant access to thousands of news articles, educational resources, research summaries, treatment best practices, and more — with commentary and insights from our distinguished team of industry thought leaders and subject matter experts.

Gain Instant Access

PsychU Radio Is On Air!

Tune in Monday-Friday from 8am-8pm ET for a live stream of interviews and audio presentations covering the mental health information that matters to you

Upcoming Virtual Forums

PsychU Virtual Forums are designed to be interactive conversations between mental health professionals and the PsychU community

Request A Custom Program

PsychU offers private, personalized education programs both online and in person on a range of topics, including: schizophrenia, major depression, care coordination, quality standards, and health care policy.
New This Week

Community Recommendations

PsychUFollow668299

PsychU members share one belief: improved information & collaboration will lead to better mental health care and patient outcomes https://t.co/Bp5St0eDA5

PsychU

#Schizophrenia affects ~1% of the U.S. population – but the annual cost is estimated at $60B. Predicting relapse in patients with #schizophrenia is one way to address the costs. The Relapse Assessment In Schizophrenia Patients tool (RASP) may help: https://t.co/m9Y3XJHliA #PsychU

Twitter feed video.Image for the Tweet beginning: #Schizophrenia affects ~1% of the

This #PsychU research summary discusses the evidence behind auditory sensory dysfunction in patients with #schizophrenia, and the mechanisms by which these deficits may contribute to the #BehavioralHealth manifestations of the disease. Read on: https://t.co/JpbA3fdDsa

Twitter feed video.Image for the Tweet beginning: This #PsychU research summary discusses

#Mentalhealth perspectives that matter on #PsychU: Accurately measuring functional outcomes in individuals with #schizophrenia is important to evaluating progress over time, but it can be difficult to quantify: https://t.co/6cYHxYxyVX

Twitter feed video.Image for the Tweet beginning: #Mentalhealth perspectives that matter on

“Digital technology is poised to become the fourth wave of evolution of #MentalHealth care,” said Philip Harvey, PhD of @umiamimedicine in this #PsychU presentation on the role of #technology in cognitive remediation in #schizophrenia: https://t.co/RWJ80OrXwr

Twitter feed video.Image for the Tweet beginning: “Digital technology is poised to

Long-term D2 receptor blockades by first- & second-generation antipsychotics can lead to drug-induced supersensitivity psychosis and movement disorders for patients with #schizophrenia. Read more on #PsychU: https://t.co/Qd5zJtBMJU

Twitter feed video.Image for the Tweet beginning: Long-term D2 receptor blockades by

#PsychU goes beyond the #monoamines in the upcoming 10/9 Virtual Forum on the evolution of #pharmacology in major #depression. Register now: https://t.co/xi7RiSn5HQ #PsychU

Twitter feed video.Image for the Tweet beginning: #PsychU goes beyond the #monoamines

“It is always important to consider the clinical benefits of [antipsychotic medication] against the side-effects.” Hear more from the experts about striking a balance between symptom control & tolerability in this #PsychU Archived Virtual Forum: https://t.co/bR7xMb9xkG #PsychU

Twitter feed video.Image for the Tweet beginning: “It is always important to

Hospital #TreatmentTeams – this #PsychU resource has data and strategies to help ensure continuity of care & relapse reduction through careful discharge planning for patients with #schizophrenia. Download it today: https://t.co/8sQg8iVcMF

Twitter feed video.Image for the Tweet beginning: Hospital #TreatmentTeams – this #PsychU

The #PsychU resource library has info on #SuicidePrevention – ranging from raising awareness to combatting #MentalHealth #stigma to recognizing warning signs. Learn more in our library today: https://t.co/r7Il4vUVVv #UICanPreventSuicide #NPSADay

Twitter feed video.Image for the Tweet beginning: The #PsychU resource library has



Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU

Our Supporters

Become A Supporter

Now Leaving PsychU

This link will take you outside of the PsychU community website.

By selecting continue, you will be leaving PsychU. The destination site to which you will be redirected is not controlled or endorsed by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and / or Lundbeck, LLC.

Continue to link outside of PsychU Remain on PsychU website
×

Now Leaving PsychU

This link will take you to a website outside of PsychU.org.

Continue To External Website Remain On PsychU.org
×

You are attempting to log out of PsychU, please confirm.

Log Out Return
×